Skip to main content

TFDP2 KO cell line available to order. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 10.

Be the first to review this product! Submit a review

Images

Sanger Sequencing - Human TFDP2 (DP2) knockout HEK-293T cell line (AB267291), expandable thumbnail

Key facts

Cell type
HEK-293T
Species or organism
Human
Tissue
Kidney
Form
Liquid
Knockout validation
Sanger Sequencing
Mutation description
Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 10

Alternative names

Recommended products

TFDP2 KO cell line available to order. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 10.

Key facts

Cell type
HEK-293T
Form
Liquid
Mutation description
Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 10
Concentration
Loading...

Properties

Gene name
TFDP2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous

Quality control

STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Female

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium
DMEM (High Glucose) + 10% FBS
Cryopreservation medium
Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Storage

Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Notes

Recommended control: Human wild-type HEK293T cell line (ab255449). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

DP2 also known as CRTH2 or GPR44 is a receptor from the class of G protein-coupled receptors (GPCRs). It is involved in the signaling pathways mediated by prostaglandins making it an essential mediator in inflammatory processes. The molecular mass of this receptor is approximately 44 kDa. DP2 is broadly expressed in various tissues including the lungs eosinophils Th2 cells and basophils highlighting its role in immune response and respiratory function. Its expression in numerous cell types underlines its versatile roles within the immune system.

Biological function summary

DP2 functions as a receptor for prostaglandin D2 (PGD2) an important lipid mediator in inflammation. DP2's activities are a part of PGD2-driven processes including the recruitment and activation of Th2 cells eosinophils and basophils which are integral to allergic responses. DP2 does not form part of a larger protein complex but operates in concert with prostanoids such as the D-type prostanoid (DP1) receptors highlighting its specific signaling pathway within the immune context. By mediating chemotaxis and activation of specific immune cells DP2 supports the perpetuation of Th2-type inflammation.

Pathways

DP2 plays a role in the prostaglandin signaling pathway and immune response network. It operates parallel to receptors like DP1 albeit delivering contrasting cellular outcomes. While DP1 typically signals via a cAMP-dependent pathway DP2 mediates its effects through calcium mobilization and beta-arrestin-dependent pathways. These pathways contribute to distinct yet overlapping roles in processes of allergy and inflammation illustrating how DP2 function is intricately connected with other signaling molecules including chemoattractant receptors involved in leukocyte trafficking.

Associated diseases and disorders

The dysregulation of DP2 is associated with asthma and allergic rhinitis. Within the context of asthma DP2 expression correlates with severity and exacerbation of the disease. The receptor's role in mediating eosinophil and Th2 cell attraction makes it a target of interest for therapeutic interventions. In allergic rhinitis similar mechanisms involving DP2-mediated immune cell recruitment exacerbate mucosal inflammation during allergen exposure. DP2's interaction with other inflammatory mediators such as the cysteinyl leukotriene receptor family solidifies its position in the cascade of allergic and respiratory disorders.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

1 product image

  • Sanger Sequencing - Human TFDP2 (DP2) knockout HEK-293T cell line (ab267291), expandable thumbnail

    Sanger Sequencing - Human TFDP2 (DP2) knockout HEK-293T cell line (ab267291)

    Homozygous: 1 bp insertion in exon10

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com